Skip to main content
Article thumbnail
Location of Repository

Time-dependent dual effects of high levels of unconjugated bilirubin on the human blood-brain barrier lining

By Inês Palmela, Hiroyuki Sasaki, Filipa L. Cardoso, Miguel Moutinho, Kwang S. Kim, Dora Brites and Maria A. Brito


In neonatal jaundice, high levels of unconjugated bilirubin (UCB) may induce neurological dysfunction (BIND). Recently, it was observed that UCB induces alterations on brain microvasculature, which may facilitate its entrance into the brain, but little is known about the steps involved. To evaluate if UCB damages the integrity of human brain microvascular endothelial cells (HBMECs), we used 50 or 100 μM UCB plus human serum albumin, to mimic the neuropathological conditions where levels of UCB free species correspond to moderate and severe neonatal jaundice, respectively. Our results point to a biphasic response of HBMEC to UCB depending on time of exposure. The early response includes increased number of caveolae and caveolin-1 expression, as well as upregulation of vascular endothelial growth factor (VEGF) and its receptor 2 (VEGFR-2) with no alterations of the paracellular permeability. In contrast, effects by sustained hyperbilirubinemia are the reduction in zonula occludens (ZO)-1 and β-catenin levels and thus of tight junctions (TJ) strands and cell-to-cell contacts. In addition, reduction of the transendothelial electrical resistance (TEER) and increased paracellular permeability are observed, revealing loss of the barrier properties. The 72 h of HBMEC exposure to UCB triggers a cell response to the stressful stimulus evidenced by increased autophagy. In this later condition, the UCB intracellular content and the detachment of both viable and non-viable cells are increased. These findings contribute to understand why the duration of hyperbilirubinemia is considered one of the risk factors of BIND. Indeed, facilitated brain entrance of the free UCB species will favor its parenchymal accumulation and neurological dysfunction

Topics: Neuroscience
Publisher: Frontiers Media S.A.
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (1999). A b b r u s c a t o ,T .J . ,a n dD a v i s ,T .P .
    2. (2007). Á b r a h á m ,C .S . ,a n dD e l i ,M .A .
    3. (2006). A h l f o r s ,C .E . ,M a l i k
    4. (2009). A h l f o r s ,C .E . ,W e n n b e r g,R .P . ,O s t r o w
    5. (2012). accepted: 23
    6. (2009). Altered functional development of the blood-brain barrier after early life stress in the rat.
    7. (2000). Assessment of bilirubin toxicity to erythrocytes. Implication in neonatal jaundice management.
    8. (2005). Autophagy and signaling: their role in cell survival and cell death.
    9. (2009). Autophagy mediates the mitotic senescence transition.
    10. (2007). Autophagy: process and function.
    11. (2010). B o l a ñ o s ,J .P . ,B r i t e s
    12. (2001). Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells.
    13. (2007). Bilirubin disrupts BBB transendothelial properties
    14. (2002). Bilirubin produces apoptosis in cultured bovine brain endothelial cells. Brain Res.
    15. (2012). Bilirubin toxicity,” in Neonatal Jaundice, eds
    16. (2001). Bilirubinalbumin binding and free bilirubin.
    17. (2002). Blood-brain barrier breakdown in septic encephalopathy and brain tumours.
    18. (2012). Blood-brain barrier in health and disease,” in The Blood-Brain Barrier: New Research, e d sP .A .M o n t e n e g r oa n dS .M . Juárez (Nova Science Publishers),
    19. (2012). C a r d o s o ,F .L . ,K i t t e l ,A . ,V e s z e l k a , S . ,P a l m e l a ,I . ,T ó t h ,A .
    20. (2009). C a r v e y ,P .M . ,H e n d e y ,B . ,a n d
    21. (2007). Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells.
    22. (2009). Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells.
    23. (2011). Cerebellar axon/myelin loss, angiogenic sprouting, and neuronal increase of vascular endothelialgrowthfactor inapreterm infant with kernicterus.
    24. (2010). Chronic bilirubin encephalopathy: diagnosis and outcome.
    25. (2005). D e l i ,M .A . ,Á b r a h á m
    26. (2004). Development by self-digestion: molecular mechanisms and biological functions of autophagy.
    27. (2010). Differentiation of the brain vasculature: the answer came blowing by the Wnt.
    28. (2010). Diphtheria toxin mutant CRM197-mediated transcytosis across blood-brain barrier in vitro.
    29. (2011). Elevated levels of bilirubin and long-term exposure impair human brain microvascular endothelial cell integrity.
    30. (1966). Experimental bilirubin encephalopathy. The mode of entry of bilirubin-14C into the central nervous system.
    31. (2009). Expression of endothelial phosphorylated caveolin-1 is increased in brain injury.
    32. (2004). F e r n a n d e s ,A . ,S i l v a ,R .F . ,F a l c ã o , A .S . ,B r i t o ,M .A . ,a n dB r i t e s ,
    33. (2011). Fas-associated factor 1 antagonizes Wnt signaling by promoting β-catenin degradation.
    34. (2006). G o r d o ,A .C . ,G a m a ,
    35. (2005). H2O2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44/42 MAP kinase pathway.
    36. (1988). Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat.
    37. (2010). Histone deacetylase 7 controls endothelial cell growth through modulation of β-catenin.
    38. (2011). In vitro models of the blood-brain barrier.
    39. (2010). Induction of cell growth arrest by atmospheric nonthermal plasma in colorectal cancer cells.
    40. (2002). Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation.
    41. (2000). K a b e y a ,Y . ,M i z u s h i m a ,N . ,U e n o
    42. (2004). K i m ,K .J . ,C h e o n g ,Y .H . ,K i m
    43. (1997). Kernicteric findings atautopsy intwo sick nearterm infants.
    44. (2008). LC3 and Autophagy. Methods Mol.
    45. (2008). Lipid mediators of autophagy in stress-induced premature senescence of endothelial cells.
    46. (2010). Lipopolysaccharide-activated microglia induce dysfunction of the bloodbrain barrier in rat microvascular endothelial cells co-cultured with microglia.
    47. (2010). Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches.
    48. M.,andCross,M.J.(2007).Vascular endothelial growth factor receptor2, structure, function, intracellular signalling and therapeutic inhibition.
    49. (2002). Mechanisms of bilirubin toxicity: clinical implications.
    50. (2009). Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin.
    51. (2001). Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier.
    52. (2002). N o i r i ,E . ,a n dG o l i g o r s k y ,M .S .
    53. (2000). N u s r a t ,A . ,P a r k o s ,C .A . ,V e r k a d e , P . ,F o l e y
    54. (2011). Noncanonical β-catenin degradation mediates reactive oxygen speciesinduced epidermal cell death.
    55. (2012). o u t i n h oM ,K i mK S ,B r i t e sD and Brito MA (2012) Time-dependent dualeffects ofhighlevels of unconjugated bilirubin on the human blood-brain barrier lining.
    56. (2007). Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction.
    57. (2003). P a t t e r s o n ,C . ,G i n g r a s ,D . ,a n d Béliveau,
    58. (2009). Pathology and new players in the pathogenesis of brain edema.
    59. R e i s ,M . ,F e l i c i ,A . ,W o l b u r g
    60. (2007). R o m e r o ,I .A . ,C o u r a u d
    61. (2009). Regulation mechanisms and signaling pathways of autophagy.
    62. (2010). S i l v a ,R .F .M . ,a n dB r i t e s , D.
    63. (2010). Structure and function of the blood-brain barrier.
    64. (2000). The blood-brain barrier and bilirubin encephalopathy.
    65. (2007). The control of endothelial cell functions by adherens junctions.
    66. (2011). The dynamic nature of autophagy in cancer.
    67. The multiple languages of endothelial cell-to-cell communication.Arterioscler.
    68. (1972). The ready isomerization of bilirubin IX-α in aqueous solution.
    69. (2010). The role of caveolae in endothelial cell dysfunction with a focusonnutritionandenvironmental toxicants.
    70. (2008). The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semiquantitative immunoblotting.
    71. (2006). Unconjugated bilirubin modulates the intestinal epithelial barrier function in a human-derived in vitro model.
    72. (2010). Understanding neonatal jaundice: a perspective on causation.
    73. (2011). W a n g ,P . ,L i u ,Y . ,S h a n g ,X . ,a n dX u e ,
    74. (2009). W e i s s ,N . ,M i l l e r ,F . ,C a z a u b o n
    75. (2008). Z h o n g ,Y . ,S m a r t ,E .J . ,W e k s l e r

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.